410 related articles for article (PubMed ID: 24580081)
1. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
Sharifi M; Lewiecki EM
Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
[TBL] [Abstract][Full Text] [Related]
2. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
3. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Pickar JH; Mirkin S
Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
[TBL] [Abstract][Full Text] [Related]
4. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
5. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Pinkerton JV; Pickar JH; Racketa J; Mirkin S
Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
[TBL] [Abstract][Full Text] [Related]
6. Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
Stovall DW
Curr Opin Investig Drugs; 2010 Apr; 11(4):464-71. PubMed ID: 20336595
[TBL] [Abstract][Full Text] [Related]
7. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Palacios S; Currie H; Mikkola TS; Dragon E
Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
[TBL] [Abstract][Full Text] [Related]
8. Advances in menopausal therapy: the tissue-selective estrogen complex.
Moore A
J Am Assoc Nurse Pract; 2013 Mar; 25(3):126-33. PubMed ID: 24218199
[TBL] [Abstract][Full Text] [Related]
9. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
Komm BS; Mirkin S; Jenkins SN
Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
[TBL] [Abstract][Full Text] [Related]
10. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
Pinkerton JV; Stovall DW
Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353
[TBL] [Abstract][Full Text] [Related]
11. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
Smith CL; Santen RJ; Komm B; Mirkin S
Breast Cancer Res; 2014 Jun; 16(3):212. PubMed ID: 25928299
[TBL] [Abstract][Full Text] [Related]
12. The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms.
Kagan R
J Womens Health (Larchmt); 2012 Sep; 21(9):975-81. PubMed ID: 22759213
[TBL] [Abstract][Full Text] [Related]
13. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
Tella SH; Gallagher JC
Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
[TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
Mirkin S; Ryan KA; Chandran AB; Komm BS
Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
[TBL] [Abstract][Full Text] [Related]
15. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
Mirkin S; Komm BS; Pan K; Chines AA
Climacteric; 2013 Jun; 16(3):338-46. PubMed ID: 23038989
[TBL] [Abstract][Full Text] [Related]
16. Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women.
Palacios S; Mejía Ríos A
Drugs Today (Barc); 2015 Feb; 51(2):107-16. PubMed ID: 25756066
[TBL] [Abstract][Full Text] [Related]
17. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
Lewiecki EM
Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629
[TBL] [Abstract][Full Text] [Related]
18. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
[TBL] [Abstract][Full Text] [Related]
19. Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
Pinkerton JV; Harvey JA; Lindsay R; Pan K; Chines AA; Mirkin S; Archer DF;
J Clin Endocrinol Metab; 2014 Feb; 99(2):E189-98. PubMed ID: 24438370
[TBL] [Abstract][Full Text] [Related]
20. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
Bachmann G; Bobula J; Mirkin S
Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
